Jpmorgan Chase & Co »

Homology Medicines shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Homology Medicines shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Homology Medicines

Tip: Access up to 7 years of quarterly data

All positions including Homology Medicines held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Homology Medicines by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $580 954 0.61
2023-09-30 $1.1k 954 1.17
2023-06-30 $844 954 0.88
2023-03-31 $426k 413k 1.03
2022-12-31 $433k 413k 1.05
2022-06-30 $1.4M 710k 2.04
2022-03-31 $2.2M 733k 3.04
2021-12-31 $2.9M 787k 3.62
2021-03-31 $21M 2.2M 9.41
2020-12-31 $39M 3.4M 11.29
2020-09-30 $31M 2.9M 10.43
2020-06-30 $42M 2.8M 15.19
2020-03-31 $35M 2.3M 15.29
2019-12-31 $46M 2.2M 20.70
2019-09-30 $39M 2.1M 18.10
2019-06-30 $39M 2.0M 19.31
2019-03-31 $55M 2.0M 27.73
2018-12-31 $50M 2.2M 22.36
2018-09-30 $52M 2.3M 22.97
2018-06-30 $35M 1.7M 20.40
2018-03-31 $23M 1.2M 18.70